Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling

Blood

Volumn 122, Issue 6, 2013, Pages 1072-1078

  Locatelli, Franco ^a,b   Kabbara, Nabil ^c   Ruggeri, Annalisa ^c   Ghavamzadeh, Ardeshir ^d   Roberts, Irene ^e   Li, Chi Kong ^f   Bernaudin, Françoise ^g   Vermylen, Christiane ^h   Dalle, Jean Hugues ⁱ   Stein, Jerry ^j   Wynn, Robert ^k   Cordonnier, Catherine ^l   Pinto, Fernando ^e   Angelucci, Emanuele ^m   Socié, Gérard ⁿ   Gluckman, Eliane ^c   Walters, Mark C ^o   Rocha, Vanderson ^c,p  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c SAINT LOUIS HOSPITAL   (France)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁱ HÔPITAL ROBERT DEBRÉ   (France)

^j SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^k ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^l HENRI MONDOR HOSPITAL   (France)

^m EBMT Hemoglobinopathy Registry   (France)

ⁿ Hô pital Saint Louis   (France)

^o CHILDREN S HOSPITAL OAKLAND   (United States)

^p UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; HLA ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; BLEEDING; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT INFECTION; GRAFT RECIPIENT; HLA SYSTEM; HUMAN; IMMUNOPROPHYLAXIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING; SICKLE CELL ANEMIA; SURVIVAL RATE; THALASSEMIA MAJOR; TREATMENT FAILURE; ADOLESCENT; ADULT; COMPARATIVE STUDY; CYTOLOGY; FETUS BLOOD; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMOGLOBINOPATHY; IMMUNOLOGY; INFANT; METABOLISM; METHODOLOGY; MULTIVARIATE ANALYSIS; THROMBOCYTE; TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BLOOD PLATELETS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FETAL BLOOD; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMOGLOBINOPATHIES; HLA ANTIGENS; HUMANS; INFANT; MALE; MULTIVARIATE ANALYSIS; NEUTROPHILS; SIBLINGS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84886897873     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-03-489112     Document Type: Article

References (38)

1. Borgna-Pignatti C., Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89(10): 1187-1193. (Pubitemid 39390442)
2. Borgna-Pignatti C., Cappellini MD, De Stefano P, et al. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood. 2006; 107(9): 3733-3737.
3. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010; 376(9757): 2018-2031.
4. Thomas ED, Buckner CD, Sanders J.E., et al. Marrow transplantation for thalassaemia. Lancet. 1982; 2(8292): 227-229. (Pubitemid 12081767)
5. Lucarelli G, Galimberti M, Giardini C., et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann N Y Acad Sci. 1998; 850(6): 270-275. (Pubitemid 28369767)
6. Lucarelli G, Clift RA, Galimberti M, et al. Bone marrow transplantation in adult thalassemic patients. Blood. 1999; 93(4): 1164-1167. (Pubitemid 29076130)
7. Walters MC, Patience M, Leisenring W., et al. Bone marrow transplantation for sickle cell disease. N Engl J Med. 1996; 335(6): 369-376. (Pubitemid 26257244)
8. Panepinto JA, Walters MC, Carreras J, et al.; Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol. 2007; 137(5): 479-485. (Pubitemid 46698289)
9. Bernaudin F, Socié G, Kuentz M, et al; SFGM-TC. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007; 110(7): 2749-2756. (Pubitemid 47523201)
10. Bernardo ME, Piras E, Vacca A., et al. Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood. 2012; 120(2): 473-476.
11. Locatelli F, Stefano PD. New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies. Br J Haematol. 2004; 125(1): 3-11. (Pubitemid 38453271)
12. La Nasa G., Giardini C, Argiolu F., et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood. 2002; 99(12): 4350-4356. (Pubitemid 34627200)
13. Hongeng S, Pakakasama S, Chaisiripoomkere W., Chuansumrit A, Sirachainan N, Ungkanont A., Jootar S. Outcome of transplantation with unrelated donor bone marrow in children with severe thalassaemia. Bone Marrow Transplant. 2004; 33(4): 377-379. (Pubitemid 38313085)
14. Fleischhauer K, Locatelli F, Zecca M., et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood. 2006; 107(7): 2984-2992.
15. Gluckman E, Locatelli F. Umbilical cord blood transplants. Curr Opin Hematol. 2000; 7(6): 353-357.
16. Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz M.M., Gluckman E; Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000; 342(25): 1846-1854. (Pubitemid 30419048)
17. Herr AL, Kabbara N, Bonfim C.M., et al. Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT. Blood. 2010; 116(11): 1849-1856.
18. Issaragrisil S, Visuthisakchai S, Suvatte V., et al. Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia. N Engl J Med. 1995; 332(6): 367-369.
19. Lau YL, Ma ES, Ha S.Y., et al. Sibling HLA-matched cord blood transplant for beta-thalassemia: report of two cases, expression of fetal hemoglobin, and review of the literature. J Pediatr Hematol Oncol. 1998; 20(5): 477-481. (Pubitemid 29133206)
20. Brichard B, Vermylen C, Ninane J., Cornu G. Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr. 1996; 128(2): 241-243. (Pubitemid 26065950)
21. Locatelli F, Rocha V, Reed W., et al.; Eurocord Transplant Group. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003; 101(6): 2137-2143. (Pubitemid 36302049)
22. Rubinstein P, Dobrila L, Rosenfield R.E., et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995; 92(22): 10119-10122.
23. Glucksberg H, Storb R, Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974; 18(4): 295-304.
24. Storb R, Prentice RL, Sullivan K.M., et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med. 1983; 98(4): 461-466. (Pubitemid 13116613)
25. Gooley TA, Leisenring W, Crowley J., Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999; 18(6): 695-706. (Pubitemid 29126745)
26. Fine JP, Grey RJ. A proportional hazards model for sub distribution of a competing risk. J Am Stat Assoc. 1999; 94(446): 496-509.
27. Cox DR. Regression models and life tables. J R Stat Soc [Ser A]. 1972; 34(6): 187-202.
28. Bizzetto R, Bonfim C, Rocha V., et al.; Eurocord and SAA-WP from EBMT. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica. 2011; 96(1): 134-141.
29. Boncimino A, Bertaina A, Locatelli F. Cord blood transplantation in patients with hemoglobinopathies. Transfus Apheresis Sci. 2010; 42(3): 277-281.
30. Inamoto Y, Flowers ME. Treatment of chronic graft-versus-host disease in 2011. Curr Opin Hematol. 2011; 18(6): 414-420.
31. Gluckman E, Ruggeri A, Volt F., Cunha R, Boudjedir K, Rocha V. Milestones in umbilical cord blood transplantation. Br J Haematol. 2011; 154(4): 441-447.
32. Lisini D, Zecca M, Giorgiani G., et al. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling. Haematologica. 2008; 93(12): 1859-1867.
33. Wu CJ, Gladwin M, Tisdale J., et al. Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis. Br J Haematol. 2007; 139(3): 504-507. (Pubitemid 47512177)
34. Kean LS, Manci EA, Perry J, et al. Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease. Blood. 2003; 102(13): 4582-4593. (Pubitemid 37494128)
35. Andreani M, Manna M, Lucarelli G., et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood. 1996; 87(8): 3494-3499. (Pubitemid 26115383)
36. Ruggeri A, Eapen M, Scaravadou A., et al.; Eurocord Registry; Center for International Blood and Marrow Transplant Research; New York Blood Center. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant. 2011; 17(9): 1375-1382.
37. Gluckman E, Rocha V, Ionescu I., et al.; EurocordNetcord and EBMT. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant. 2007; 13(9): 1073-1082. (Pubitemid 47215564)
38. Gluckman E, Ruggeri A, Rocha V., et al.; Eurocord, Netcord, World Marrow Donor Association and National Marrow Donor Program. Family-directed umbilical cord blood banking. Haematologica. 2011; 96(11): 1700-1707.